Ochre Bio (YC Winter 2020)

TL;DR: Ochre Bio is a Y Combinator Winter 2020 startup RNA medicines for liver diseases, currently active with a team of 50.

RNA medicines for liver diseases

YC ID
13672
YC Batch
Winter 2020
Status
Active
Team size
50
Industry
Healthcare, Therapeutics
Tags
Biotech, Genomics
YC profile
https://www.ycombinator.com/companies/ochre-bio

Last verified:

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Frequently asked questions

Is Ochre Bio a YC (Y Combinator) company?

Yes. Ochre Bio was funded by Y Combinator in the Winter 2020 batch. RNA medicines for liver diseases

What does Ochre Bio do?

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.

What YC batch was Ochre Bio in?

Ochre Bio was part of Y Combinator's Winter 2020 batch.

How big is Ochre Bio?

Ochre Bio has a team of 50 people according to Y Combinator's directory.

Is Ochre Bio still active?

Ochre Bio is currently listed as Active with a team of 50 in Y Combinator's directory.

More YC Winter 2020 companies

More Healthcare YC startups

Explore related YC hubs

Loading interactive view…